These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 29013912)

  • 41. A new class of insecticide for malaria vector control: evaluation of mosquito nets treated singly with indoxacarb (oxadiazine) or with a pyrethroid mixture against Anopheles gambiae and Culex quinquefasciatus.
    Oxborough RM; N'Guessan R; Kitau J; Tungu PK; Malone D; Mosha FW; Rowland MW
    Malar J; 2015 Sep; 14():353. PubMed ID: 26377930
    [TBL] [Abstract][Full Text] [Related]  

  • 42. In vivo antiplasmodial and toxicological effect of Maytenus senegalensis traditionally used in the treatment of malaria in Tanzania.
    Malebo HM; Wiketye V; Katani SJ; Kitufe NA; Nyigo VA; Imeda CP; Ogondiek JW; Sunguruma R; Mhame PP; Massaga JJ; Mammuya B; Senkoro KP; Rumisha SF; Malecela MN; Kitua AY
    Malar J; 2015 Feb; 14():79. PubMed ID: 25890324
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical symptoms, treatment and outcome of highlands malaria in Eldoret (2420 m a.s.l.) and comparison to malaria in hyper-immune population in endemic region of Southern Sudan.
    Benca J; Dubai A; Sladeckova V
    Neuro Endocrinol Lett; 2007 Nov; 28 Suppl 3():35-6. PubMed ID: 18030278
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [A new case of Plasmodium falciparum malaria resistance to chloroquine in Africa (Rwanda) (author's transl)].
    Mafart Y; Pieron R; Melchior JC
    Med Trop (Mars); 1981; 41(6):677-80. PubMed ID: 7040906
    [TBL] [Abstract][Full Text] [Related]  

  • 45. M 3, a New Drug in the Treatment of Malaria.
    Chopra RN; Roy DN; Hayter RTM; Sen B
    Ind Med Gaz; 1940 Jan; 75(1):19-20. PubMed ID: 29013912
    [No Abstract]   [Full Text] [Related]  

  • 46. Treatment of falciparum malaria in the age of drug resistance.
    Shanks GD
    J Postgrad Med; 2006; 52(4):277-80. PubMed ID: 17102546
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Withdrawing antimalarial drugs: impact on parasite resistance and implications for malaria treatment policies.
    Laufer MK; Plowe CV
    Drug Resist Updat; 2004; 7(4-5):279-88. PubMed ID: 15533765
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Current status of malaria chemotherapy and the role of pharmacology in antimalarial drug research and development.
    Na-Bangchang K; Karbwang J
    Fundam Clin Pharmacol; 2009 Aug; 23(4):387-409. PubMed ID: 19709319
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Development of new drugs for chemoprophylaxis of malaria.
    Milhous WK
    Med Trop (Mars); 2001; 61(1):48-50. PubMed ID: 11584654
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Drug repositioning in the treatment of malaria and TB.
    Nzila A; Ma Z; Chibale K
    Future Med Chem; 2011 Sep; 3(11):1413-26. PubMed ID: 21879845
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Malaria drug resistant: current situation with reference to Saudi Arabia (review).
    Al-Harthi SA
    J Egypt Soc Parasitol; 2011 Dec; 41(3):553-64. PubMed ID: 22435149
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Atovaquone/proguanil for the prophylaxis and treatment of malaria.
    Patel SN; Kain KC
    Expert Rev Anti Infect Ther; 2005 Dec; 3(6):849-61. PubMed ID: 16307498
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Current drugs for the treatment of tropical malaria].
    Fernex M; Jaquet C; Mittelholzer ML; Reber R; Stürchler D
    Schweiz Rundsch Med Prax; 1991 Jan; 80(4):67-71. PubMed ID: 1998081
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Advances in nanomedicines for malaria treatment.
    Aditya NP; Vathsala PG; Vieira V; Murthy RS; Souto EB
    Adv Colloid Interface Sci; 2013 Dec; 201-202():1-17. PubMed ID: 24192063
    [TBL] [Abstract][Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 3.